| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 05/06/2009 | EP2055773A1 Uncoupled productive and catabolic host cell pathways |
| 05/06/2009 | EP2054529A2 Methods for in vivo identification of endogenous mrna targets of micrornas |
| 05/06/2009 | EP2054520A2 A novel method for assembling dna metasegments to use as substrates for homologous recombination in a cell |
| 05/06/2009 | EP2054505A2 Nucleic acid quantitation from tissue slides |
| 05/06/2009 | EP2054430A2 Promiscuous her-2/neu cd4 t cell epitopes |
| 05/06/2009 | EP2054428A2 Development of dengue virus vaccine components |
| 05/06/2009 | EP2054077A2 Polypeptide derivatives of parathyroid hormone (pth) |
| 05/06/2009 | EP1934613A4 Sequences for detection and identification of methicillin-resistant staphylococcus aureus (mrsa) of mrej types xi to xx |
| 05/06/2009 | EP1563092A4 Assays and methods based on microcompetition with a foreign polynucleotide |
| 05/06/2009 | EP1556404B1 Genetically engineered p30 antigen, improved antigen cocktail, and uses thereof |
| 05/06/2009 | EP1539785B1 Gene regulation in transgenic animals using a transposon-based vector |
| 05/06/2009 | EP1224271B1 Expression of recombinant mature lysostaphin |
| 05/06/2009 | EP1212457B1 Uv excitable fluorescent energy transfer dyes |
| 05/06/2009 | CN101426906A A novel class of therapeutic protein based molecules |
| 05/06/2009 | CN101426805A Method for detaching protecting group on nucleic acid |
| 05/06/2009 | CN101426804A Method of capping oligonucleic acid |
| 05/06/2009 | CN101426535A DNA virus microrna and methods for inhibiting same |
| 05/06/2009 | CN101426370A Immunostimulatory oligonucleotide multimers |
| 05/06/2009 | CN101423865A Human Toll-like receptor 7 gene mononucleotide polymorphism and use thereof |
| 05/06/2009 | CN101423542A Extraction method of cubilose whole genome DNA |
| 05/06/2009 | CN101423541A Separation method of nucleic acid and glycosaminoglycan |
| 05/06/2009 | CN100485036C Fennero penaeus chinensis antibacterial protein gene and recombinant expression and use |
| 05/06/2009 | CN100485034C Oligonucleotide extracted from mycobacterium for stimulating immunological function, treating immunity related disease, allergic dermatitis and/or protecting normal immunocyte |
| 05/05/2009 | US7528244 Protein for use in the diagnosis and treatment of cell death defects |
| 05/05/2009 | US7528243 Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer |
| 05/05/2009 | US7528242 Methods and compositions comprising Renilla GFP |
| 05/05/2009 | US7528241 Kit; nucleic acid molecules having single or multiple nucleotide overhangs; streamlining many high throughput gene expression operations |
| 05/05/2009 | US7528233 covalent heterodimer of two different neurotrophins; which have multiple neurotrophic specificities; use in treatment of nervous system disorders |
| 05/05/2009 | US7528230 Signaling polypeptide for use as reporter molecule in biosensing system |
| 05/05/2009 | US7528119 Administering to a mammal P1,P4-di(uridine 5'-)tetraphosphate, tetralithium salt; or P1,P4-di(uridine 5'-)tetraphosphate, tetrapotassium salt; in a pharmaceutically acceptable carrier to treat dry eye or retinal detachment |
| 05/05/2009 | US7528118 RNAi modulation of ApoB and uses thereof |
| 05/05/2009 | US7528117 High efficacy antisense RIαPKA poly-DNP oligoribonucleotides |
| 05/05/2009 | US7528116 Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis |
| 05/05/2009 | US7528106 Angiostatic fragment of tryptophanyl-tRNA synthetase (TrpRS) and vascular endothelial growth factor (VEGF) signaling inhibitor and an integrin signaling inhibitor; peptide, pegaptanib sodium, EMD 472523; antiangiogenic drugs |
| 05/05/2009 | US7528093 Using genetic rearrangement in genomic region associated with brain voltage-gated sodium channel to detect convulsive disorder |
| 05/05/2009 | US7527967 Recombinant baculovirus and virus-like particle |
| 05/05/2009 | US7527966 Expression vector comprising kinase nucleotide sequence for use as tool in transformation and expression of heterologus genes in mamalian cells |
| 05/05/2009 | US7527962 Nucleic acid which encode diacylglycerol acyltransferase family members; obesity |
| 05/05/2009 | US7527958 Cellulose degratory enzyme for enhancing plant fiber degradation in rumens of ruminal animals; improving beer brewing |
| 05/05/2009 | US7527957 Modifying amino acid residues of the polypeptide, measuring the sensitivity of xylanase to a xylanase inhibitor, a natural inhibitor found specifically in wheat extract |
| 05/05/2009 | US7527956 modifying the C-terminal cysteine amino acid residue of human sphingomyelinase; peptide synthesis/chemical/; increase enzyme hydrolysis activity; Niemann-Pick disease, lipid histiocytosis; genetic disorder |
| 05/05/2009 | US7527955 Glyphosate-N-acetyltransferase (GAT) genes |
| 05/05/2009 | US7527954 Compartmentalisation of nucleic acids together with an in vitro transcription-translation mixture in a water-in-oil emulsion, the expression of fusion polypeptides coded by the nucleic acids; fusion polypeptides are covalently bonded to the nucleic acid coding for the fusion polypeptide |
| 05/05/2009 | US7527953 Genes from Propionibacterium freudenreichii encoding enzymes involved in vitamin B12 biosynthesis |
| 05/05/2009 | US7527948 Detection of HPV |
| 05/05/2009 | US7527946 Angiogenesis and neovascularization inhibition; host cells, recombinant DNA; increased half life and longer vasculature retention time |
| 05/05/2009 | US7527931 Identification of a gene associated with spinocerebellar ataxia type 5 and methods of use |
| 05/05/2009 | US7527926 Oligonucleotides, reagents and amplification methods for detecting severe acute respiratory syndrome coronavirus |
| 05/05/2009 | US7527925 Purified pol DNA, a recombinant DNA construct for expression of HIV pol polypeptide sequences and a cell containing such construct |
| 05/05/2009 | US7527791 Humanized anti-TGF-beta antibodies |
| 05/05/2009 | US7527785 Using an adeno-associated viral vector to deliver a nucleotide sequence encoding a novel glutamic acid decarboxylase (GAD) to specific regions of the brain that are over stimulated or disinhibited; neurodegenerative diseases, Alzheimer's and Parkinson's disease; antiepileptic agents; drug delivery |
| 05/05/2009 | CA2319775C Compositions and methods for using a lysing matrix for isolating dna |
| 05/05/2009 | CA2233064C Polyfunctional cationic cytofectins, formulations and methods for generating active cytofectin:polynucleotide transfection complexes |
| 05/05/2009 | CA2149298C Flk-1 is a receptor for vascular endothelial growth factor |
| 04/30/2009 | WO2009055445A2 RNA INTERFERENCE MEDIATED INHIBITION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 04/30/2009 | WO2009054924A1 Novel hiv targets |
| 04/30/2009 | WO2009054873A2 Anti-rantes antibodies and methods of use thereof |
| 04/30/2009 | WO2009052572A1 Streptococcus m protein, immunogenic fragments, nucleic acids and methods of use |
| 04/30/2009 | WO2009033071A3 Novel fungal enzymes |
| 04/30/2009 | WO2009014612A3 Modified nucleotides, methods for making and using same |
| 04/30/2009 | WO2008140494A9 High throughput screening using microarrays |
| 04/30/2009 | WO2008109498A4 Nucleic acid compounds for inhibiting hdac gene expression and uses thereof |
| 04/30/2009 | WO2008109372A4 Nucleic acid compounds for inhibiting pdgf gene expression and uses thereof |
| 04/30/2009 | WO2008083150A3 Methods and vectors for generating asialylated immunoglobulins |
| 04/30/2009 | WO2008070616A3 METHODS AND COMPOSITIONS RELATED TO HIF-1α |
| 04/30/2009 | WO2008061239A3 Compositions and methods for detecting noonan syndrome |
| 04/30/2009 | WO2008036406A3 Compositions and methods related to protein displacement therapy for myotonic distrophy |
| 04/30/2009 | WO2007148235A3 Cancer-related nucleic acids |
| 04/30/2009 | WO2007103146A3 Truncated proteins as cancer markers |
| 04/30/2009 | WO2007064758A3 Methods and systems for designing primers and probes |
| 04/30/2009 | WO2007056223A3 Diagnostic tests of substance use disorders |
| 04/30/2009 | WO2007056213A3 Drug-eluting stents coated with p2y12 receptor antagonist compound |
| 04/30/2009 | WO2007047847A3 Methods for diagnosing cancer based on dna methylation status in nbl2 |
| 04/30/2009 | WO2007044245A3 Self-assembled single molecule arrays and uses thereof |
| 04/30/2009 | WO2007029249A3 Oligoribonucleotides and methods of use thereof for treatment of cardiovascular diseases |
| 04/30/2009 | WO2007027919A3 Complementation assays utilizing complexes of heteroproteins |
| 04/30/2009 | WO2007022374A3 Assessing response to anti-cd20 therapy by genotyping c1q components |
| 04/30/2009 | WO2007016702A3 Chimeric polymerases |
| 04/30/2009 | WO2007016331A3 Classification and diagnosis of the molecular basis of cholestasis |
| 04/30/2009 | WO2007009071A3 Methods of diagnosing and treating an inflammatory response |
| 04/30/2009 | WO2007005995A3 Compositions for buccal delivery of human growth hormone |
| 04/30/2009 | WO2007002746A3 Molecular/genetic aberrations in surgical margins of resected pancreatic cancer represents neoplastic disease that correlates with disease outcome |
| 04/30/2009 | WO2006138606A3 Cell signaling genes and related methods |
| 04/30/2009 | WO2006138479A3 Microstructure and microdomain microarrays, methods of making and using thereof |
| 04/30/2009 | WO2006133107A3 Specific binding sites in collagen for integrins and use thereof |
| 04/30/2009 | WO2006127980A3 Optimized core promoters and uses therefor |
| 04/30/2009 | WO2006125094A3 Combinatorial selection of phosphorothioate aptamers for rnases |
| 04/30/2009 | WO2006113546A3 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 04/30/2009 | WO2006091535A3 Novel egg receptors for sperm proteins |
| 04/30/2009 | WO2006088906A3 Modulation of muc1 activity |
| 04/30/2009 | WO2006083964A3 Modified fusion molecules for treatment of allergic disease |
| 04/30/2009 | WO2006063252A3 Compositions and methods for inducing an immune response in a mammal and methods of avoiding an immune response to oligonucleotide agents such as short interfering rnas |
| 04/30/2009 | WO2006054297A3 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 04/30/2009 | WO2006009890A3 Methods and compositions for producing insulin sensitization |
| 04/30/2009 | WO2006004867A3 Mammalian endonucleases and methods of use |
| 04/30/2009 | WO2005120583A3 Method for preventing or treating cardiac hypertrophy |
| 04/30/2009 | WO2005098016A3 Methods for producing hyaluronic acid |
| 04/30/2009 | WO2005059101A3 Novel sodium channel |
| 04/30/2009 | WO2005010158A3 Ex vivo methods and compositions for administering a rnai agent to a subject |
| 04/30/2009 | WO2004098515A3 Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer |